Literature DB >> 28256026

Histopathologic Characteristics of Intestinal Biopsy Samples from Dogs With Chronic Inflammatory Enteropathy With and Without Hypoalbuminemia.

S A Wennogle1, S L Priestnall2, C B Webb1.   

Abstract

BACKGROUND: Previous studies have identified hypoalbuminemia as a risk factor for negative outcome in dogs with chronic enteropathy (CE), but it has not been determined whether histopathology differs between CE dogs with and without hypoalbuminemia.
OBJECTIVE: To compare histopathologic findings in dogs with biopsy-diagnosed inflammatory CE with and without hypoalbuminemia. ANIMALS: 83 dogs that had intestinal biopsy performed between January 2010-July 2015. Dogs had signs compatible with CE of at least 3-weeks' duration and no evidence of clinically relevant extra-gastrointestinal (GI) disease or potential non-GI causes of hypoalbuminemia. Dogs had primary diagnosis of inflammatory enteritis based on histopathology.
METHODS: Dogs were grouped into CE with normoalbuminemia (CEN; serum albumin concentration ≥3.0 g/dL, N = 46) or chronic enteropathy with hypoalbuminemia (CEH; serum albumin concentration <3.0 g/dL, N = 37). A pathologist (SLP) blinded to the groups reviewed biopsy samples and applied the World Small Animal Veterinary Association scoring system to all samples.
RESULTS: Intestinal biopsy samples from dogs in the CEH group were significantly more likely to display villous stunting, epithelial injury, crypt distension, and lacteal dilatation, and were more likely to have intraepithelial lymphocytes and lamina propria neutrophils than biopsy samples from dogs in the CEN group. Additionally, higher scores for each of the above listed histopathologic criteria were associated with a lower serum albumin concentration. CONCLUSIONS AND CLINICAL IMPORTANCE: Histopathologic features of chronic inflammatory enteropathy differ between dogs that are hypo- versus normoalbuminemic. Additional work is needed to elucidate the clinical relevance of these differences.
Copyright © 2017 The Authors. Journal of Veterinary Internal Medicine published by Wiley Periodicals, Inc. on behalf of the American College of Veterinary Internal Medicine.

Entities:  

Keywords:  Albumin; Canine; Chronic enteropathy; Histopathology

Mesh:

Year:  2017        PMID: 28256026      PMCID: PMC5354060          DOI: 10.1111/jvim.14669

Source DB:  PubMed          Journal:  J Vet Intern Med        ISSN: 0891-6640            Impact factor:   3.175


chronic enteropathy chronic enteropathy with hypoalbuminemia chronic enteropathy with normoalbuminemia lymphoplasmacytic enteritis protein‐losing enteropathy Chronic enteropathy (CE) is a term used to describe various inflammatory conditions of the intestinal tract.1 It is characterized by the presence of gastrointestinal (GI) signs such as weight loss, vomiting, diarrhea, and decreased appetite of at least several weeks’ duration, and is associated with histologic evidence of inflammation in the small intestine.1, 2, 3 In dogs, the type of CE often is determined by response to treatment and can include antibiotic‐responsive disease, food‐responsive disease, and idiopathic inflammatory bowel disease, which may be steroid responsive.1 The prognosis is reported to be highly variable1, 2, 3, 4, 5 and dependent on response to treatment.6 When a GI disorder results in hypoalbuminemia as a consequence of excessive loss of plasma proteins through the intestinal mucosa, it is commonly referred to as protein‐losing enteropathy (PLE).7 Causes of PLE are numerous, including diseases that result in infiltration, inflammation, hemorrhage, or edema of the GI tract,7 including intestinal lymphangiectasia, alimentary lymphoma, hookworm infestation, infection by Histoplasma capsulatum, and intestinal intussusception.8 Chronic enteropathies can result in PLE,8 and for the purposes of this study, we refer to this type of PLE as chronic enteropathy with hypoalbuminemia (CEH). Although several previous studies have identified hypoalbuminemia as a risk factor for negative outcome in cases of CE, it is still unclear whether histopathology differs between CE dogs with and without hypoalbuminemia.1, 4, 5 Historically, substantial interobserver variation in histopathologic evaluation of intestinal tissue has compounded this problem,9 making it difficult to compare changes among dogs with different categories of intestinal disease. Recently, the GI Standardization Group developed guidelines for the interpretation of inflammatory change in the GI mucosa of the dog and cat. These standards, known as the World Small Animal Veterinary Association (WSAVA) scoring system, include classification and scoring of morphologic and inflammatory changes in the canine intestinal mucosa.10 The objective of our study was to compare histopathologic findings (as determined by the WSAVA scoring system) in dogs with biopsy‐diagnosed CE with and without hypoalbuminemia. Our hypothesis was that dogs with CE and hypoalbuminemia would have different histopathologic features than CE dogs without hypoalbuminemia.

Materials and Methods

Electronic medical records at Colorado State University were reviewed for dogs that had intestinal biopsy performed between January 2010 and July 2015. Included dogs had clinical signs compatible with CE of at least 3‐weeks' duration, including weight loss, diarrhea, vomiting, and decreased appetite, and intestinal biopsy samples that indicated variable types and degrees of inflammatory infiltrate. Dogs were included if their primary diagnosis was an inflammatory enteritis on their original histopathologic evaluation. Additionally, all dogs had an appropriate history of fecal testing or deworming, and most (67/83; 80%) had abdominal ultrasonography performed before intestinal biopsy to screen for intestinal or abdominal masses. Dogs with clinically relevant concurrent extra GI disease, with potential non‐GI causes of hypoalbuminemia, with causes of GI disease other than inflammatory enteritis (eg, intestinal lymphoma), or for which a complete medical record could not be obtained, were excluded. Specifically, hypoalbuminemic dogs that were not screened for proteinuria, had substantial proteinuria (UPC >1.0), or had clinically abnormal serum bile acid concentrations (preprandial >20 μmol/L; postprandial >40 μmol/L) were excluded. Dogs were placed in either the CE with normoalbuminemia (serum albumin concentration ≥3.0 g/dL) group (chronic enteropathy with normoalbuminemia, CEN) or the CE with hypoalbuminemia (serum albumin concentration <3.0 g/dL) group (CEH). Serum albumin concentration <3.0 g/dL was defined as hypoalbuminemia based on the Colorado State University Diagnostic Laboratory's normal reference interval for serum albumin concentration in dogs (3.0–4.3 g/dL). Recorded data included age, breed, sex, clinical signs, additional clinicopathologic abnormalities, tissue types available, and biopsy method. After cases were selected for study, histopathologic evaluation of previously obtained intestinal tissue was performed by a single pathologist blinded to clinical group (SLP). The pathologist established that the biopsy samples were adequate for evaluation, and then determined the presence of morphologic criteria (villous stunting, epithelial injury, crypt distension, lacteal dilatation, mucosal fibrosis) and inflammatory criteria (intraepithelial lymphocytes [IEL], lamina propria eosinophils, lamina propria lymphocytes or plasma cells, lamina propria neutrophils) and scored the degree of change based on WSAVA guidelines. For the degree of each change, the following scores were applied based on established criteria: 0 = normal, 1 = mild, 2 = moderate, 3 = marked. In cases where >1 tissue type was available, the tissue type with the highest total WSAVA score was used in the analysis.

Statistical Analysis

The proportion of each variable present was compared between the 2 groups (CEN versus CEH) using Fisher's exact test. A Spearman (rank‐based) correlation also was performed to evaluate for a correlation between score for each biopsy variable and serum albumin concentration. A multiple logistic regression analysis then was performed using those variables found to be significantly associated with hypoalbuminemia based on Fisher's exact test (crypt distention, IEL, lacteal dilatation, neutrophils, villous epithelial injury, and villous stunting). Specifically, hypoalbuminemia (yes or no) was the response variable and the histopathologic variables (presence/absence) were used as predictors. Backward elimination then was used to decrease the number of predictors in the logistic regression model. For Fisher's exact test and Spearman's correlation analyses, a Bonferroni adjustment was used to account for multiple testing. Statistical significance for all analyses was defined as the probability of the null hypotheses (ie, no relationship or no difference) being true at <5.0% (P < .05).

Results

Medical records of 270 dogs that underwent intestinal biopsy at CSU (Colorado State University) from January 2010 to July 2015 were reviewed. Of the 270, 83 met the inclusion criteria. Ninety‐six of the excluded dogs had either evidence of clinically relevant concurrent extra‐GI disease, or clinically relevant concurrent extra‐GI disease could not be excluded. Sixty‐four of the excluded dogs had a primary diagnosis other than inflammatory enteritis as the cause of their chronic GI signs (eg, chronic foreign body and neoplasia). In 27 excluded cases, no intestinal tissue or previously prepared slide was available for evaluation. Of the included dogs, 37/83 (45%) were hypoalbuminemic (CEH group; serum albumin concentration <3.0 g/dL), and 46/83 (55%) were normoalbuminemic (CEN group; serum albumin concentration ≥3.0 g/dL). The median age of dogs in the CEH group was 3 years (range, 1–12 years). The median age of dogs in CEN group was 2 years (range, 5 months–14 years). In the CEH group, 3 dogs were intact males, 15 dogs were castrated males, 1 dog was an intact female, and 18 dogs were spayed females. In the CEH group, 2 dogs were intact males, 30 dogs were castrated males, 2 dogs were intact females, and 12 dogs were spayed females. There was no significant difference in age or sex status between groups. Breeds included mixed breed (15), Labrador Retriever (9), German Shepherd Dog (4), Boxer (3), Cocker Spaniel (3), Pomeranian (3), West Highland White Terrier (3), Australian Shepherd (2), Border Collie (2), English Bulldog (2), French Bulldog (2), Golden Retriever (2), Great Pyrenees (2), Newfoundland (2), Yorkshire Terrier (2), and 1 each of the following: American Eskimo, Airedale Terrier, Akita, Bernese Mountain Dog, Boston Terrier, Chesapeake Bay Retriever, Doberman, Miniature Dachshund, German Shorthaired Pointer, Giant Schnauzer, Irish Setter, Maltese, Norwich Terrier, Lundehund, Rottweiler, Soft Coated Wheaten Terrier, Samoyed, Shar Pei, Shetland Sheepdog, Shiba Inu, Shih Tzu, Siberian Husky, Saint Bernard, Standard Poodle, Tibetan Terrier, and Weimaraner. In the CEH group, biopsy samples were obtained by endoscopy in 33/37 (89%) cases, with 24/33 (73%) having only gastroduodenoscopy performed and 9/33 (27%) having both gastroduodenoscopy and ileocolonoscopy performed. Three dogs in the CEH group had intestinal biopsy samples obtained celiotomy, and 1 dog by laparoscopy. In the CEN group, biopsy samples were obtained by endoscopy in 42/46 (91%) cases, with 22/42 (52%) having only gastroduodenoscopy performed and 20/42 (48%) having both gastroduodenoscopy and ileocolonoscopy performed. Four dogs in CEN group had intestinal biopsy samples obtained by celiotomy. Method of biopsy procurement was not different between groups. Median serum albumin concentration in the CEH group was 1.9 g/dL (range, 0.8–2.8 g/dL). Median serum albumin concentration in the CEN group was 3.7 g/dL (range, 3.0–4.4 g/dL). A Fisher's exact test indicated that dogs in the CEH group had a greater proportion of villous stunting, epithelial injury, crypt distension, and lacteal dilatation than did dogs in the CEN group. Additionally, dogs in the CEH group had a greater proportion of IEL and lamina propria neutrophils than did dogs in the CEN group. Proportions of lamina propria eosinophils and lamina propria lymphocytes or plasma cells were not different between groups. The criterion of mucosal fibrosis was not represented often enough to be suitable for statistical analysis (Fig 1).
Figure 1

The presence of histopathologic variables in dogs with CEH versus dogs with CEN. P values (Fischer's exact test) and adjusted P values (after Bonferroni correction) shown for significant and nonsignificant variables. *Retained significance in multivariate analysis; #Statistical tests unreliable because of low expression of this trait; LP, lamina propria; CEH, chronic enteropathy and hypoalbuminemia; CEN, chronic enteropathy and normoalbuminemia.

The presence of histopathologic variables in dogs with CEH versus dogs with CEN. P values (Fischer's exact test) and adjusted P values (after Bonferroni correction) shown for significant and nonsignificant variables. *Retained significance in multivariate analysis; #Statistical tests unreliable because of low expression of this trait; LP, lamina propria; CEH, chronic enteropathy and hypoalbuminemia; CEN, chronic enteropathy and normoalbuminemia. A rank‐based Spearman's correlation indicated that a higher score for villous stunting, epithelial injury, crypt distension, lacteal dilatation, IEL, or lamina propria neutrophils was moderately associated with a lower serum albumin concentration (Table 1).
Table 1

Scores for histopathologic variables in dogs with chronic enteropathy and correlation with hypoalbuminemia (Spearman rank‐based)

VariableGroupMedMinMaxSpearman's Correlation Score P ValueAdjusted P Valuea
Crypt distensionCEH103−0.587<.001<.001
CEN002
Intraepithelial lymphocytesCEH003−0.347.001.01
CEN001
Lacteal dilatationCEH103−0.422<.001<.001
CEN003
EosinophilsCEH002−0.09.421
CEN003
Lymphocytes and plasma cellsCEH102−0.157.161
CEN002
NeutrophilsCEH003−0.308.005.04
CEN002
Mucosal fibrosisCEH001NANANA
CEN000
Villous epithelial injuryCEH003−0.372<.001.005
CEN001
Villous stuntingCEH103−0.551<.001<.001
CEN0.502

CEH, chronic enteropathy with hypoalbuminemia; CEN, chronic enteropathy with normoalbuminemia; LP, lamina propria; NA, not applicable: statistical tests unreliable due to low expression of this trait.

After Bonferroni correction.

Scores for histopathologic variables in dogs with chronic enteropathy and correlation with hypoalbuminemia (Spearman rank‐based) CEH, chronic enteropathy with hypoalbuminemia; CEN, chronic enteropathy with normoalbuminemia; LP, lamina propria; NA, not applicable: statistical tests unreliable due to low expression of this trait. After Bonferroni correction. After backward elimination (using alpha = 0.05), multiple logistic regression analysis indicated that the following variables remained significant: crypt distension (odds ratio [OR], 12.487; P < .001), intraepithelial lymphocytes (OR, 10.060; P = .013), and lacteal dilatation (OR, 5.037; P = .009). The OR represents the odds of hypoalbuminemia comparing the presence versus the absence of each histopathologic variable, with other variables held constant.

Discussion

Lymphoplasmacytic or eosinophilic intestinal infiltrates or both are considered the hallmark of idiopathic CE. In our population of dogs with CE, the proportions of lamina propria lymphoplasmacytic or eosinophilic infiltrates were not different between the hypoalbuminemic and normoalbuminemic groups. Additionally, the proportions and severity of these infiltrates were not correlated with serum albumin concentration. This finding was not surprising, and it is in agreement with previous studies, in which the histologic scores of infiltrates of eosinophils, lymphocytes, or plasma cells were not correlated with the patient's serum albumin concentration or outcome.1, 5 Interestingly, the cellular infiltrates that were different between CEH and CEN dogs included IEL and lamina propria neutrophils. Intraepithelial lymphocytes are a component of the first line of defense in the GI immune system and have both pro‐ and anti‐inflammatory roles.11, 12 We found that IEL were more likely to be present (P < .001) in dogs with hypoalbuminemia versus normoalbuminemic dogs with CE, but as a consequence of the retrospective nature of our study, we were not able to classify these cells further. Additional study is needed to determine the role of these cells in dogs with CE. Lamina propria neutrophils were more likely to be present (P = .003) in dogs with hypoalbuminemia (17/37; 46%) compared to dogs with normoalbuminemia (7/46; 15%). Whether the neutrophils are representative of an underlying etiology, are present because of adhesion and possible translocation of microbial flora or pathogens, or are simply part of the inflammatory response is not well understood and deserves further study. Crypt distension also was found more often in dogs with CEH versus dogs with CEN (P < .001). Previous studies have reported on crypt lesions, sometimes referred to as crypt abscesses, in dogs with PLE.13 In a case series of 6 dogs with PLE,14 only 2/6 had inflammatory infiltrates or lymphangiectasia histologically. Interestingly, both dogs that had inflammatory infiltrates had neutrophils noted in the lamina propria, and 5/6 dogs had neutrophils present in distended crypts. In another series of 58 dogs with CE, dogs with crypt abscesses were found to have more severe intestinal protein loss and shorter survival times than dogs with crypt distension or no crypt lesions.15 The clinical relevance of crypt lesions in dogs with CE also deserves further study. Dilated lacteals were present in a high proportion of dogs overall (44/83; 53%), but were significantly more likely (P < .001) to be present in dogs with hypoalbuminemia (28/37; 76%) compared to dogs with normal serum albumin concentration (16/46; 35%). A previous retrospective analysis of full‐thickness intestinal biopsy samples in dogs with chronic GI disease showed that, in 38/64 dogs (59%), the major histopathologic abnormality was intestinal lymphangiectasia (dilated lacteals). Lymphoplasmacytic enteritis (LPE) was identified in only 5/64 dogs (8%).16 These findings are in contrast to a study that evaluated histologic findings of endoscopic biopsy samples in 368 dogs with chronic diarrhea, where LPE was identified in approximately 25% of cases, and lymphangiectasia was not common.17 The serum albumin concentration of dogs in these studies was not compared. A more recent study evaluated the histologic features of 136 dogs with chronic GI signs, 94 with LPE, and 42 with GI disease not caused by inflammatory bowel disease. All 94 dogs with LPE had lacteal dilatation graded as moderate to severe by WSAVA standards. Additionally, lacteal height, width, and height/width ratio were inversely correlated with serum albumin concentration in this group of dogs.18 The reason for the discrepancies among the studies likely is multifactorial, but could include the fact that intestinal lymphangiectasia may be segmental or multifocal and biopsies may miss these lesions if the affected area is not sampled. Most of the biopsy samples in our study were obtained endoscopically with the potential to miss lesions deep within the submucosal and muscularis layers of the intestinal wall.19 Nonetheless, the high prevalence of intestinal lymphangiectasia in dogs with a primary diagnosis of inflammatory enteritis may be important. Although secondary lymphangiectasia is thought to resolve with treatment targeting idiopathic inflammatory bowel disease, it may be that dogs not responding to this treatment would benefit from fat restriction because of persistent intestinal lymphangiectasia. Also, lymphatic dysfunction and lymphangiogenesis have long been suspected as a component of the pathology of inflammatory bowel diseases in humans, and therapeutic interventions to stimulate lymphatic function have shown some promise in recent experimental murine models of inflammatory bowel disease.20, 21, 22, 23 In a previous study of dogs with diet‐responsive enteropathy, WSAVA histopathologic scoring identified more villous stunting in the enteropathy dogs versus controls.24 Ultrastructural lesions of the mitochondria and brush border also were evaluated and in those dogs clinically responsive to food, and the microvillus height and additional ultrastructural lesions improved. The authors postulated that the recovery of enterocyte health after clinical response to diet suggests that architectural changes may be at least as important as more standard measures of pathology in the intestine, namely inflammatory infiltrates. It was suggested that this might explain why previous studies have failed to identify improvement in the inflammatory infiltrates of dogs with CE, despite clinical improvement.24 Our study is in agreement that the morphologic lesions appear to be important in dogs with CE. Additionally, because these lesions were more common in hypoalbuminemic dogs, we suspect they may indicate a more severe form of CE. Whether the presence or relative severity of these lesions indicates a possible alternative etiology or the need for alternative treatment approaches is unknown. A prospective study in which clinical data and response to treatment can be monitored based on the histologic criteria is warranted. Our study had several limitations. The median age of dogs in our CEH and CEN groups was younger (CEH, 3 years; CEN, 2 years) when compared to other studies of dogs with CE.1, 25, 26, 27, 28 Therefore, our population of dogs with CE may not reflect those seen at other institutions. Additionally, the retrospective design of our study did not allow us to determine the dogs that had received proper food or antibiotic trials before intestinal biopsy so that we could better classify them. Therefore, we applied the term CE to these cases, rather than idiopathic inflammatory bowel disease. However, at our institution, it is common for food and antibiotic trials to be completed before the recommendation of biopsy, provided the patient is stable. Response to treatment and prognosis as it relates to the above histopathologic features could not be determined because of incomplete follow‐up of many of the cases. Most biopsy samples were obtained endoscopically, which is the standard of practice at our institution but does have limitations, as described above.19 Also, ileal biopsy samples (via ileocolonoscopy, celiotomy, or laparoscopy) were obtained in just 35% of dogs with CEH and 57% of dogs with CEN. The method of biopsy sample procurement was not different between groups, but a larger proportion of the CEN dogs had ileal biopsy samples obtained, which may have affected the results. Pathology can differ among sections of small intestine,26, 29 and ideally, ileal biopsy samples would have been available for evaluation in all dogs. Finally, despite the use of the WSAVA guidelines for histopathologic scoring of endoscopic intestinal biopsy samples, substantial interobserver variability occurs, controversy still exists, and scoring is still considered relatively subjective.30 In conclusion, many histopathologic features of chronic inflammatory enteropathy differ between dogs that are hypo‐ versus normoalbuminemic. The classic features of CE, lymphoplasmacytic cellular infiltrate and eosinophilic infiltrates, were not different between groups, whereas other inflammatory infiltrates and many of the morphologic features were different. These morphologic lesions may simply indicate a more severe disease process occurring in the intestine. Additional work is needed to elucidate the clinical relevance of these differences and to determine whether the presence or relative severity of these lesions indicates a possible alternative etiology or the need for alternative or supplemental treatment strategy in some cases of CE in dogs.
  28 in total

1.  Interobserver variation among histopathologic evaluations of intestinal tissues from dogs and cats.

Authors:  Michael D Willard; Albert E Jergens; Robert B Duncan; Michael S Leib; Malcolm D McCracken; Robert C DeNovo; Rowland G Helman; Margaret R Slater; Jacque L Harbison
Journal:  J Am Vet Med Assoc       Date:  2002-04-15       Impact factor: 1.936

2.  Endoscopic, biopsy, and histopathologic guidelines for the evaluation of gastrointestinal inflammation in companion animals.

Authors:  R J Washabau; M J Day; M D Willard; E J Hall; A E Jergens; J Mansell; T Minami; T W Bilzer
Journal:  J Vet Intern Med       Date:  2010 Jan-Feb       Impact factor: 3.333

3.  Fecal S100A12 concentration predicts a lack of response to treatment in dogs affected with chronic enteropathy.

Authors:  Romy M Heilmann; Maria Volkmann; Cristiane C Otoni; Niels Grützner; Barbara Kohn; Albert E Jergens; Jörg M Steiner
Journal:  Vet J       Date:  2016-03-07       Impact factor: 2.688

4.  Duodenal endoscopic findings and histopathologic confirmation of intestinal lymphangiectasia in dogs.

Authors:  R N Larson; J A Ginn; C M Bell; M J Davis; D S Foy
Journal:  J Vet Intern Med       Date:  2012-07-24       Impact factor: 3.333

5.  Prognostic factors in dogs with protein-losing enteropathy.

Authors:  K Nakashima; S Hiyoshi; K Ohno; K Uchida; Y Goto-Koshino; S Maeda; N Mizutani; A Takeuchi; H Tsujimoto
Journal:  Vet J       Date:  2015-05-06       Impact factor: 2.688

Review 6.  Emerging roles of lymphatics in inflammatory bowel disease.

Authors:  J Steven Alexander; Ganta Vijay Chaitanya; M B Grisham; Moheb Boktor
Journal:  Ann N Y Acad Sci       Date:  2010-10       Impact factor: 5.691

7.  Evaluation of serum biochemical marker concentrations and survival time in dogs with protein-losing enteropathy.

Authors:  Mirjam Equilino; Vincent Théodoloz; Daniela Gorgas; Marcus G Doherr; Romy M Heilmann; Jan S Suchodolski; Jörg M Steiner; Iwan A Burgener Dvm
Journal:  J Am Vet Med Assoc       Date:  2015-01-01       Impact factor: 1.936

8.  Idiopathic inflammatory bowel disease in dogs and cats: 84 cases (1987-1990).

Authors:  A E Jergens; F M Moore; J S Haynes; K G Miles
Journal:  J Am Vet Med Assoc       Date:  1992-11-15       Impact factor: 1.936

9.  A comprehensive pathological survey of duodenal biopsies from dogs with diet-responsive chronic enteropathy.

Authors:  D Walker; A Knuchel-Takano; A McCutchan; Y-M Chang; C Downes; S Miller; K Stevens; K Verheyen; A D Phillips; S Miah; M Turmaine; A Hibbert; J M Steiner; J S Suchodolski; K Mohan; J Eastwood; K Allenspach; K Smith; O A Garden
Journal:  J Vet Intern Med       Date:  2013-05-10       Impact factor: 3.333

10.  Low Vitamin D Status Is Associated with Systemic and Gastrointestinal Inflammation in Dogs with a Chronic Enteropathy.

Authors:  Helen F Titmarsh; Adam G Gow; Scott Kilpatrick; Jennifer A Cartwright; Elspeth M Milne; Adrian W Philbey; Jacqueline Berry; Ian Handel; Richard J Mellanby
Journal:  PLoS One       Date:  2015-09-02       Impact factor: 3.240

View more
  12 in total

1.  Identification of matrix metalloproteinase-2 and -9 activities within the intestinal mucosa of dogs with chronic enteropathies.

Authors:  Mohsen Hanifeh; Minna Marjaana Rajamäki; Pernilla Syrjä; Laura Mäkitalo; Susanne Kilpinen; Thomas Spillmann
Journal:  Acta Vet Scand       Date:  2018-03-12       Impact factor: 1.695

Review 2.  Comparative pathophysiology and management of protein-losing enteropathy.

Authors:  Melanie D Craven; Robert J Washabau
Journal:  J Vet Intern Med       Date:  2019-02-14       Impact factor: 3.333

Review 3.  Narrative review of therapies for chronic enteropathies in dogs and cats.

Authors:  Kelly Makielski; Jonah Cullen; Annette O'Connor; Albert E Jergens
Journal:  J Vet Intern Med       Date:  2018-12-06       Impact factor: 3.333

4.  Lymphatic endothelial cell immunohistochemical markers for evaluation of the intestinal lymphatic vasculature in dogs with chronic inflammatory enteropathy.

Authors:  Sara A Wennogle; Simon L Priestnall; Alejandro Suárez-Bonnet; Sirikul Soontararak; Craig B Webb
Journal:  J Vet Intern Med       Date:  2019-06-06       Impact factor: 3.175

Review 5.  Review of cobalamin status and disorders of cobalamin metabolism in dogs.

Authors:  Stefanie Kather; Niels Grützner; Peter H Kook; Franziska Dengler; Romy M Heilmann
Journal:  J Vet Intern Med       Date:  2019-11-23       Impact factor: 3.333

6.  Association between intestinal lymphangiectasia and expression of inducible nitric oxide synthase in dogs with lymphoplasmacytic enteritis.

Authors:  Takuro Nagahara; Koichi Ohno; Itsuma Nagao; Taisuke Nakagawa; Yuko Goto-Koshino; Masaya Tsuboi; James K Chambers; Kazuyuki Uchida; Hirotaka Tomiyasu; Hajime Tsujimoto
Journal:  J Vet Med Sci       Date:  2021-12-01       Impact factor: 1.267

7.  Evaluation of the degree and distribution of lymphangiectasia in full-thickness canine small intestinal specimens diagnosed with lymphoplasmacytic enteritis and granulomatous lymphangitis.

Authors:  Takuro Nagahara; Koichi Ohno; Itsuma Nagao; Taisuke Nakagawa; Yuko Goto-Koshino; Masaya Tsuboi; James K Chambers; Kazuyuki Uchida; Hirotaka Tomiyasu; Hajime Tsujimoto
Journal:  J Vet Med Sci       Date:  2022-03-14       Impact factor: 1.105

Review 8.  Clinical utility of currently available biomarkers in inflammatory enteropathies of dogs.

Authors:  Romy M Heilmann; Jörg M Steiner
Journal:  J Vet Intern Med       Date:  2018-09-17       Impact factor: 3.333

9.  Comparison of clinical, clinicopathologic, and histologic variables in dogs with chronic inflammatory enteropathy and low or normal serum 25-hydroxycholecalciferol concentrations.

Authors:  Sara A Wennogle; Simon L Priestnall; Alejandro Suárez-Bonnet; Craig B Webb
Journal:  J Vet Intern Med       Date:  2019-09-09       Impact factor: 3.175

10.  Ki-67/CD3 ratio in the diagnosis of chronic inflammatory enteropathy in dogs.

Authors:  Sonja Karlovits; Anita Manz; Karin Allenspach; Ingrid Walter; Stefan Kummer; Alexander Tichy; Barbara Richter; Iwan A Burgener; Nicole Luckschander-Zeller
Journal:  J Vet Intern Med       Date:  2019-12-11       Impact factor: 3.333

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.